We are live on
!
Find out more
S
SharpePoint Portfolio holdings
AUM
$168M
1-Year Est. Return
48.18%
This Fund
S&P 500
This Quarter
Est. Return
+17.38%
1 Year Est. Return
+48.18%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$97.2M
AUM Growth
-$17M
(-15%)
Cap. Flow
-$28.7M
Cap. Flow
% of AUM
-29.55%
Top 10 Holdings %
Top 10 Hldgs %
43.51%
Holding
79
New
2
Increased
29
Reduced
10
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PIMCO Multi Sector Bond Active ETF
PYLD
|
+$1.97M |
| 2 |
Noble Corp
NE
|
+$1.05M |
| 3 |
Strive FAANG 2.0 ETF
FTWO
|
+$490K |
| 4 |
PR
Permian Resources
PR
|
+$314K |
| 5 |
Williams Companies
WMB
|
+$205K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$6.38M |
| 2 |
CrowdStrike
CRWD
|
+$3.43M |
| 3 |
GE Vernova
GEV
|
+$3.37M |
| 4 |
Vanguard Growth ETF
VUG
|
+$2.58M |
| 5 |
Tesla
TSLA
|
+$2.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.33% |
| 2 | Energy | 12.77% |
| 3 | Technology | 12.28% |
| 4 | Communication Services | 5.46% |
| 5 | Financials | 5.28% |
Similar funds
IWA
OIM
AWP
YWM
CCG
WAM
WBWA
KIM
SharpePoint's Q2 2025 Portfolio in Review
As of Q2 2025, SharpePoint held 79 positions worth $97.2M, down 15% from $114M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
SharpePoint withdrew a net $28.7M in Q2 2025, closing 36 positions and reducing 10 holdings. Its most notable exit was Eli Lilly, an estimated $6.38M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 16% a quarter earlier, followed by Energy and Technology.
Against the trend, SharpePoint opened a new position in Noble Corp worth $1.17M.
- SharpePoint's largest Q2 2025 buy was Noble Corp: 43,901 shares worth $1.17M.
- SharpePoint added most to PIMCO Multi Sector Bond Active ETF in Q2 2025, an estimated $1.97M increase.
- SharpePoint's biggest Q2 2025 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $349K.
- SharpePoint fully exited Eli Lilly in Q2 2025, selling an estimated $6.38M.
- SharpePoint's ten largest holdings make up 44% of its $97.2M portfolio in Q2 2025.
- SharpePoint opened 2 new positions and closed 36 in Q2 2025.
- SharpePoint's portfolio value fell 15% quarter-over-quarter to $97.2M.
Based on SharpePoint's 13F filing for Q2 2025, filed 11 Aug 2025.